Skip to main content
Signal8

Capps Kathleen S.

SEC insider (Form 3/4/5 filer). CIK 0002085127. Officer at ENANTA PHARMACEUTICALS INC (ENTA). 4 reported Form 4/5 transactions since Sep 2024; latest on Dec 5, 2025. Located in WATERTOWN, MA.

Companies Capps Kathleen S. has filed insider reports for

  • ENANTA PHARMACEUTICALS INC (ENTA): Officer, See Remarks
Capps Kathleen S. profile photo

Capps Kathleen S.

CIK: 0002085127

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ENANTA PHARMACEUTICALS INC logo
ENTA

ENANTA PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • ENANTA PHARMACEUTICALS INC logo
    ENTA

    ENANTA PHARMACEUTICALS INC

    Dec 5, 2025
    Sale
    Direct
    323 shares at avg. $14.23$5K
  • ENANTA PHARMACEUTICALS INC logo
    ENTA

    ENANTA PHARMACEUTICALS INC

    Dec 2, 2025
    Sale
    Direct
    207 shares at avg. $13.96$3K
  • ENANTA PHARMACEUTICALS INC logo
    ENTA

    ENANTA PHARMACEUTICALS INC

    Dec 1, 2025
    Tax Payment
    Direct
    85 shares at avg. $14.12$1K
  • ENANTA PHARMACEUTICALS INC logo
    ENTA

    ENANTA PHARMACEUTICALS INC

    Nov 25, 2025
    Award
    Direct
    3.2K shares-

1-4 of 4